When treating cancer patients, it’s no longer an either/or world.
It’s all about the AND. It’s time to consider molecular information from both tissue AND blood. CTC AND ctDNA.
At Biocept, we are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy.